Tenofovirdizoproksil Pliva 245 mg filmom obložene tablete
Name | Tenofovirdizoproksil Pliva 245 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-373118482 |
Active Substance | tenofovirdizoproksilfumarat |
Composition | jedna filmom obložena tableta sadrži 245 mg tenofovirdizoproksila (u obliku fumarata) |
Pharmaceutical Form | filmom obložena tableta |
Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-373118482-01] 90 tableta u blisteru, u kutiji [HR-H-373118482-02] 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-373118482-03] 90 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-373118482-04] 30 tableta u bočici, u kutiji [HR-H-373118482-05] 30 tableta u bočici u kutiji, 3 pakiranja u kutiji [HR-H-373118482-06] |
Manufacturer | Teva Pharmaceutical Works Private Limited Company, Debrecen, Mađarska
Pharmachemie B.V., Haarlem, Nizozemska Merckle GmbH, Ulm, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Teva Operations Poland Sp. z o.o., Krakow, Poljska |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 25.09.2019 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/387 |
Registration Number | 381-12-01/30-19-06 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J05AF07 |
Medicinal product marketed in the Croatia | Nestašica |
SmPC | download |
PL | download |
Public Assessment Report | download |